Fineline Cube

Follow:
14778 Articles
Innovent's Fortvita Stake Sale Sparks Controversy, Shares Plummet Nearly 13%
CompanyDeals

Innovent’s Fortvita Stake Sale Sparks Controversy, Shares Plummet Nearly 13%

Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System
CompanyMedical Device

Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System

Novartis Secures FDA Accelerated Approval for Scemblix in Newly Diagnosed CML Patients
CompanyDrug

Novartis Secures FDA Accelerated Approval for Scemblix in Newly Diagnosed CML Patients

MGI Tech Partners with OncoDNA to Enhance Precision Oncology Solutions
CompanyDeals

MGI Tech Partners with OncoDNA to Enhance Precision Oncology Solutions

Mindray Reports Q3 2024 Financials: International Revenues Surge Over 18% Amid Domestic Challenges
CompanyMedical Device

Mindray Reports Q3 2024 Financials: International Revenues Surge Over 18% Amid Domestic Challenges

BeiGene CCO Yin Min Detained Amid Investigation; Company Affirms Compliance Standards
Company

BeiGene CCO Yin Min Detained Amid Investigation; Company Affirms Compliance Standards

Biogen Partners with Neomorph to Develop Molecular Glue Degraders for Alzheimer’s and Rare Diseases
CompanyDeals

Biogen Partners with Neomorph to Develop Molecular Glue Degraders for Alzheimer’s and Rare Diseases

Yantai Dongcheng Pharma Secures FDA Fast-Track Designation for 177Lu-LNC1004 in Thyroid Cancer
CompanyDrug

Yantai Dongcheng Pharma Secures FDA Fast-Track Designation for 177Lu-LNC1004 in Thyroid Cancer

Sunshine Guojian Pharmaceutical Secures NMPA Approval for Clinical Trials of SSGJ-626 in Lupus Indications
CompanyDrug

Sunshine Guojian Pharmaceutical Secures NMPA Approval for Clinical Trials of SSGJ-626 in Lupus Indications

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions
CompanyDrug

Zai Lab Reports Positive Phase III Results for KarXT, Showcasing Efficacy in Psychiatric Conditions

Sun-Novo Pharmaceuticals Gets Green Light for CAR-T Therapy Clinical Trial in Lupus Treatment
CompanyDrug

Sun-Novo Pharmaceuticals Gets Green Light for CAR-T Therapy Clinical Trial in Lupus Treatment

GSK Secures Global Rights to Chimagen Biosciences' T Cell-Engager in $850 Million Deal
CompanyDeals

GSK Secures Global Rights to Chimagen Biosciences’ T Cell-Engager in $850 Million Deal